FAMAR, a portfolio company of private equity investor MidEuropa, has agreed to acquire a sterile manufacturing site in Homburg (Saar), Germany, from MiP Pharma. The move enhances FAMAR’s position in the CDMO sector by strengthening its capabilities in high-value dosage
FAMAR, a contract development and manufacturing organisation (CDMO), has been acquired by MidEuropa, a European private equity investor. The agreement, signed by ECM Partners and Metric Capital Partners, marks a significant shift in FAMAR’s ownership structure. The transaction, announced on
With a legacy spanning 75 years, FAMAR has firmly established itself as a leading European Contract Development and Manufacturing Organization (CDMO) for pharmaceutical and cosmetic products. Ahead of CDMO Live, FAMAR explain their strategic plans for growth and commitment to
FAMAR is a Manufacturer/Innovator, Contract Service company operating in the pharmaceutical industry. FAMAR is a leading European service provider for the development and production of pharmaceutical and cosmetic products(CDMO), with a legacy of more than 70 years of expertise and
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
